Last price paid | 3.45 | |
Change | +4.23% [ +0.14 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 11.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 09.09.2022 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +195.95% |
Year to date (YTD) | +89.56% |
1 month | +16.95% |
3 months | +24.55% |
1 year | +82.54% |
3 years | n.a. |
Issue price | 1.11 |
Underlying price on issue | 18.03 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1206971249 |
Symbol | IXGAAZ |
Security | 120697124 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Troy Ounce of Silver |
Underlying ISIN | XC0009653103 |
Funding level | 16.201300 |
Stop-loss level | 16.626800 |
Distance to stop-loss level | 46.02% |
Long/Short type | Long |
Subscription ratio | 4.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 02.09.2022 |
Premium | 0.21% |
Premium p.a. | n.a. |
Leverage | 2.10 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 14.603000 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
NOVARTIS N | 100.24 |
Alcon AG | 81.48 |
Compagnie Financi... | 142.40 |
Sika AG | 263.80 |
Partners Group Ho... | 1'233.00 |
Name | Price |
---|---|
KUEHNE & NAGEL | 255.50 |
Givaudan | 4'336.00 |
Swiss Life Hldg | 674.00 |
Swiss Re | 110.50 |
Lonza Group | 520.20 |